Iranian journal of pathology · 2026
CD155 Expression in Invasive Breast Carcinoma: Association with Immune Tumor Microenvironment.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abdelkerim Asmaa, Khairy Ibrahim Fatma Mohamed, Oreby Radwa, Atef Aliaa, El-Desouky Karima
Аннотация
BACKGROUND & OBJECTIVE: CD155 is as an immune checkpoint molecule that interacts with various activating and inhibitory receptors on T- lymphocytes and natural killer (NK) cells in tumor microenvironment (TME). NK cells and tumor associated macrophages (TAMs) are major components of the immune TME.
METHODS: 85 cases of invasive breast carcinoma (IBC) were evaluated for immunohistochemical expression of CD155, CD56, and CD163.
RESULTS: CD155 was positive in 52.9% of cases, and was significantly associated with larger sized, higher grade, advanced stage tumors, positive lymphovascular invasion (LVI), and aggressive molecular subtypes of IBC. High density of CD56 stained tumor infiltrating NK cells was detected in 30.6% of cases, which was significantly related to larger sized, higher-grade tumors, and aggressive molecular subtypes. High density of stromal TAMs was detected in 55.3% of cases, and was significantly associated with large tumor sizes, higher grade, advanced stage, positive LVI, and aggressive molecular subtypes. CD155 expression was significantly correlated with the densities of NK cells and TAMs in TME.
CONCLUSION: CD155 expression, high density of tumor infiltrating NK cells, and high density of stromal TAMs contribute to progression of IBC. CD155 can play an important immunoregulatory role in the TME.
METHODS: 85 cases of invasive breast carcinoma (IBC) were evaluated for immunohistochemical expression of CD155, CD56, and CD163.
RESULTS: CD155 was positive in 52.9% of cases, and was significantly associated with larger sized, higher grade, advanced stage tumors, positive lymphovascular invasion (LVI), and aggressive molecular subtypes of IBC. High density of CD56 stained tumor infiltrating NK cells was detected in 30.6% of cases, which was significantly related to larger sized, higher-grade tumors, and aggressive molecular subtypes. High density of stromal TAMs was detected in 55.3% of cases, and was significantly associated with large tumor sizes, higher grade, advanced stage, positive LVI, and aggressive molecular subtypes. CD155 expression was significantly correlated with the densities of NK cells and TAMs in TME.
CONCLUSION: CD155 expression, high density of tumor infiltrating NK cells, and high density of stromal TAMs contribute to progression of IBC. CD155 can play an important immunoregulatory role in the TME.